118 related articles for article (PubMed ID: 33008767)
1. Quality of life in older survivors of non-Hodgkin's lymphoma who received chemotherapy and related factors.
Ariestine DA; Sari NK; Rinaldi I; Abdullah M
J Geriatr Oncol; 2021 Mar; 12(2):326-331. PubMed ID: 33008767
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and related demographic factors in long-term survivors of childhood non-Hodgkin's lymphoma.
Hu Y; Wu LH; Guan HJ; Wu SY; Liu LZ; Cai RQ; Xu YJ; Zhang YZ; Sun XF; Zhu J
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Sept 15; 23(9):882-888. PubMed ID: 34535201
[TBL] [Abstract][Full Text] [Related]
3. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
[TBL] [Abstract][Full Text] [Related]
4. Exploring health-related quality of life among non-Hodgkin's lymphoma survivors after completion of primary treatment: a cross-sectional study in Thailand.
Lekdamrongkul P; Pongthavornkamol K; Molassiotis A; Sriyuktasuth A; Siritanaratkul N; Chansatitporn N
Support Care Cancer; 2021 Nov; 29(11):6511-6522. PubMed ID: 33909148
[TBL] [Abstract][Full Text] [Related]
5. [A comparative study of comprehensive geriatric assessment in elder patients with non-Hodgkin's lymphoma].
Liu H; Gao M; Mei D; Han HX; Li JT; Bai JF; Zhang CL; Feng R; Wei JP; Tian Y; Wang T
Zhonghua Nei Ke Za Zhi; 2018 May; 57(5):330-334. PubMed ID: 29747287
[No Abstract] [Full Text] [Related]
6. Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy.
Park S; Hong J; Hwang I; Ahn JY; Cho EY; Park J; Cho EK; Shin DB; Lee JH
J Geriatr Oncol; 2015 Nov; 6(6):470-8. PubMed ID: 26522808
[TBL] [Abstract][Full Text] [Related]
7. Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy.
Doorduijn J; Buijt I; Holt B; Steijaert M; Uyl-de Groot C; Sonneveld P
Eur J Haematol; 2005 Aug; 75(2):116-23. PubMed ID: 16000127
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
9. Quality of Life and Impact of Cancer: Differences in Rural and Nonrural Non-Hodgkin's Lymphoma Survivors.
Noonan D; LeBlanc M; Conley C; Benecha H; Leak-Bryant A; Peter K; Zimmerman S; Mayer D; Smith S
J Rural Health; 2020 Sep; 36(4):536-542. PubMed ID: 32472708
[TBL] [Abstract][Full Text] [Related]
10. Differences in quality of life between non-Hodgkin's lymphoma survivors meeting and not meeting public health exercise guidelines.
Vallance JK; Courneya KS; Jones LW; Reiman T
Psychooncology; 2005 Nov; 14(11):979-91. PubMed ID: 15744764
[TBL] [Abstract][Full Text] [Related]
11. Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi.
Merli F; Bertini M; Luminari S; Mozzana R; Bertè R; Trottini M; Stelitano C; Botto B; Pizzuti M; Quintana G; De Paoli A; Federico M;
Haematologica; 2004 Aug; 89(8):973-8. PubMed ID: 15339681
[TBL] [Abstract][Full Text] [Related]
12. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
[TBL] [Abstract][Full Text] [Related]
13. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
[TBL] [Abstract][Full Text] [Related]
14. Independence and health related quality of life in 200 onco-geriatric surgical patients within 6 months of follow-up: Who is at risk to lose?
Baier P; Ihorst G; Wolff-Vorbeck G; Hüll M; Hopt U; Deschler B
Eur J Surg Oncol; 2016 Dec; 42(12):1890-1897. PubMed ID: 27519617
[TBL] [Abstract][Full Text] [Related]
15. Home-based multidimensional survivorship programmes for breast cancer survivors.
Cheng KKF; Lim YTE; Koh ZM; Tam WWS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma.
Lemieux C; Ahmad I; Bambace NM; Bernard L; Cohen S; Delisle JS; Fleury I; Kiss T; Mollica L; Roy DC; Sauvageau G; Roy J; Lachance S
Biol Blood Marrow Transplant; 2020 Jan; 26(1):157-161. PubMed ID: 31521818
[TBL] [Abstract][Full Text] [Related]
17. Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG).
Rüffer JU; Flechtner H; Tralls P; Josting A; Sieber M; Lathan B; Diehl V;
Eur J Cancer; 2003 Oct; 39(15):2179-86. PubMed ID: 14522376
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Korean Version of the Quality of Life-Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors.
Cho J; Kang D; Kim IR; Kim WS; Ferrell B; Kim SJ
Cancer Res Treat; 2018 Jan; 50(1):204-211. PubMed ID: 28361524
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis.
Gómez H; Hidalgo M; Casanova L; Colomer R; Pen DL; Otero J; Rodríguez W; Carracedo C; Cortés-Funes H; Vallejos C
J Clin Oncol; 1998 Jun; 16(6):2065-9. PubMed ID: 9626205
[TBL] [Abstract][Full Text] [Related]
20. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry.
Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV
Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
